| __timestamp | Lantheus Holdings, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 72471000 |
| Thursday, January 1, 2015 | 78634000 | 89204000 |
| Friday, January 1, 2016 | 75374000 | 106010000 |
| Sunday, January 1, 2017 | 92157000 | 137905000 |
| Monday, January 1, 2018 | 93326000 | 159888000 |
| Tuesday, January 1, 2019 | 103132000 | 158425000 |
| Wednesday, January 1, 2020 | 110171000 | 200677000 |
| Friday, January 1, 2021 | 218817000 | 304759000 |
| Saturday, January 1, 2022 | 233827000 | 377221000 |
| Sunday, January 1, 2023 | 267194000 | 336361000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting approaches to SG&A efficiency.
From 2014 to 2023, Lantheus Holdings saw a steady increase in SG&A expenses, peaking at approximately 267 million in 2023, a 270% rise from 2014. In contrast, Supernus Pharmaceuticals experienced a more dramatic increase, with expenses soaring by over 360% to reach around 336 million in 2023.
This divergence highlights differing strategic priorities. While both companies have expanded their operations, Supernus's more aggressive spending suggests a focus on rapid growth and market penetration. Meanwhile, Lantheus's more measured increase may indicate a balanced approach, prioritizing sustainable growth and cost management.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Novo Nordisk A/S or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights